Ethylene

Ethylene

SCHEMBL6142256

C=C.S=C(C(=S)c1ccccc1)c1ccccc1.S=C(C(=S)c1ccccc1)c1ccccc1.[Ni]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MAPT P10636 3/20 0.44
AKT1 P31749 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
HSP90AA1 P07900 1/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
KMT2A Q03164 1/20 0.42
CES1 P23141 3/20 0.41
CES2 O00748 2/20 0.41
TSHR P16473 2/20 0.41
DAO P14920 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
POLB P06746 2/20 0.38
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
F12 P00748 1/20 0.38
F7 P08709 1/20 0.38
F3 P13726 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5683621 0.94 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL1508905 0.94 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL10339337 0.91 ALDH1A1 (0.50) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL6933327 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL8527536 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL31182128 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL10989883 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL10981499 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL10985626 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1
SCHEMBL10991460 0.88 ALDH1A1 (0.48) ALDH1A1MAPTAKT1L3MBTL1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492746-A1 SELECTIVE COUPLING OF TERMINAL OLEFINS WITH ETHYLENE TO MANUFACTURE LINEAR ALPHA-OLEFINS ExxonMobil Research and Engineering Company (US) 2005-01-05 EP disclosed
US-6777584-B2 USING ORGANOMETALLIC CATALYST EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2004-08-17 US disclosed
US-20030166985-A1 Selective coupling of terminal olefins with ethylene to manufacture linear alpha-olefins EXXONMOBIL RESEARCH & ENGINEERING COMPANY 2003-09-04 US disclosed
WO-2003072529-A1 SELECTIVE COUPLING OF TERMINAL OLEFINS WITH ETHYLENE TO MANUFACTURE LINEAR ALPHA-OLEFINS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2003-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166985-A1 Selective coupling of terminal olefins with ethylene to manufacture linear alpha-olefins EEF1D, CYP4Z1, ECH1 ALDH1A1 2839/4885MAPT 2316/4885AKT1 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.